Navigation Links
Aviva Systems Biology Acquires GenWay Biotech
Date:2/23/2017

SAN DIEGO, Feb. 23, 2017 /PRNewswire/ -- Aviva Systems Biology Corporation (ASB) which supplies protein research tools, announced the acquisition of GenWay Biotech Incorporated, a protein solutions and applications provider with a comprehensive service and product offering for both the research and diagnostic markets.

"This acquisition will facilitate growth and enhance capabilities for both entities. GenWay's 18 years of experience producing proteins, antibodies, and ELISA assays will nicely complement ASB's objective to become a leading provider of proteomic solutions," said Peter Jiang, M.D., ASB's Chief Executive Officer. "We see opportunities to expand both ASB's and GenWay's existing businesses as a result from this acquisition."

"We expect a smooth transition for both companies and their respective customers," said Matt Landry, ASB's Vice President of Marketing and Sales. Prior to joining ASB in 2010, Mr. Landry was the Senior Vice President of Marketing and Sales for GenWay Biotech. He played a critical role in leading GenWay's product and service divisions from 2004 to 2010.

GenWay Biotech maintains ISO13485 accreditation for the development, validation, and production of antibodies and proteins for use in FDA regulated or CE marked products. The company also offers clinical laboratory services in a CAP accredited, CLIA facility. The company's services and products are offered to customers in research, diagnostic, and government institutions. This transaction will uniquely position ASB as a leader in product development, production, and services to assist customers with their research and diagnostic needs.

About Aviva Systems Biology

Aviva Systems Biology Corporation is a leader in antibody manufacturing. The company aims to enable life science research discoveries by developing novel antibodies. To date, the company has manufactured over 50,000 antibodies against more than 20,000 human gene targets. They help customers optimize proteomic assays, accelerate life science research, improve reproducibility, and discover novel protein targets. ASB's head office is in San Diego, CA. They also have offices in Beijing and Tianjin China. For more information, please visit www.avivasysbio.com.

About GenWay Biotech

Since 1998, GenWay Biotech Incorporated has provided the research community with proteomic solutions and applications by offering a comprehensive catalog of products and services. To date, GenWay scientists have produced thousands of proteins and antibodies at their San Diego facility. The company strives to provide customized solutions to each project. GenWay's head office is in San Diego, CA as well. For more information, please visit www.genwaybio.com.

CONTACT:  Matt Landry, 858-552-6979, mlandry@avivasysbio.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aviva-systems-biology-acquires-genway-biotech-300412060.html


'/>"/>
SOURCE Aviva Systems Biology Corporation
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Masy Systems Now NVLAP Accredited To Perform RH Calibrations
2. Masy Systems Increases Validation Personnel in Pennsylvania and New Jersey
3. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
4. Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
5. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
6. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
7. Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research
8. Ingenuity Systems IPA Provides Researchers with Genomic Insights Suggesting that Physical Activity Does Not Slow Muscle Aging
9. R&D Systems is Offering Travel Grants to Attend the 15th International Congress of Immunology
10. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
11. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation ... Physics and Astronomy, has been selected for membership in ARCS Alumni Hall of ... Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of the ...
(Date:10/9/2017)... Antonio, Texas (PRWEB) , ... ... ... new study published on October 5, 2017, in the medical journal, Epilepsia, ... equivalence with the gold standard, video EEG, in detecting generalized tonic-clonic seizures ...
Breaking Biology Technology:
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
Breaking Biology News(10 mins):